1 – 10 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
The DNA methylation landscape of primary triple-negative breast cancer
(
- Contribution to journal › Article
- 2024
-
Mark
RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer
(
- Contribution to journal › Article
- 2023
-
Mark
Molecular characteristics of lung adenocarcinoma with respect to patient age at diagnosis
(
- Contribution to journal › Article
- 2021
-
Mark
A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis
(
- Contribution to journal › Article
-
Mark
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms
(
- Contribution to journal › Article
- 2020
-
Mark
Deep sequencing of myxoinflammatory fibroblastic sarcoma
(
- Contribution to journal › Article
-
Mark
Genomic and transcriptomic features of dermatofibrosarcoma protuberans : Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor development
(
- Contribution to journal › Article
-
Mark
Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma
(
- Contribution to journal › Article
-
Mark
Methylation patterns and chromatin accessibility in neuroendocrine lung cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Aberrant receptor tyrosine kinase signaling in lipofibromatosis : a clinicopathological and molecular genetic study of 20 cases
(
- Contribution to journal › Article